Fredun Pharmaceuticals Acquires Wagr.ai

Fredun Pharmaceuticals Limited (BSE - FREDUN | 539730) is one of the leading pharmaceuticals formulation manufacturing companies in India. The Company, diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and Animal Healthcare Products, today announced the strategic acquisition of all assets of Wagr, a leading pet tech platform, marking the launch of India's first truly neutral online marketplace for pet products and services.

This strategic move positions FPL at the forefront of India's rapidly growing pet care industry, projected to reach $6 billion by 2030.

The acquisition includes Wagr's comprehensive technology platform, user base of 140,000+ pet parents, patented pet fitness tracking technology, and established veterinary network-creating an unprecedented ecosystem that addresses critical gaps in the Indian pet care market.

FPL will relaunch the Wagr marketplace and services in Q4 FY 2025-26.

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 1418.70 as compared to the previous close of Rs. 1423.40. The total number of shares traded during the day was 11462 in over 465 trades.

The stock hit an intraday high of Rs. 1448.00 and intraday low of 1390.10. The net turnover during the day was Rs. 16255289.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals INE194R01017 Acquisition Wagrai